Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

SI

Shoulder Innovations Inc

Dec 08 • 04:00PM ET

14.78

-0.42 -2.76 %

Healthcare • Medical Devices • USA • NYSE

Held by: IWM VXF IWO VTI VTWO IWN IWC RSSL VTWG VTWV

Index	RUT	P/E	-	EPS (ttm)	-1.79	Insider Own	52.67%	Shs Outstand	20.58M	Perf Week	2.07%
Market Cap	304.50M	Forward P/E	-	EPS next Y	-	Insider Trans	7.83%	Shs Float	9.75M	Perf Month	31.73%
Enterprise Value	182.13M	PEG	-	EPS next Q	-0.38	Inst Own	32.37%	Short Float	2.45%	Perf Quarter	-1.34%
Income	-36.38M	P/S	7.31	EPS this Y	-	Inst Trans	107.30%	Short Ratio	2.49	Perf Half Y	-
Sales	41.63M	P/B	2.06	EPS next Y	-	ROA	-32.08%	Short Interest	0.24M	Perf YTD	-1.79%
Book/sh	7.18	P/C	2.22	EPS next 5Y	-	ROE	-57.29%	52W High	17.94 -17.61%	Perf Year	-
Cash/sh	6.66	P/FCF	-	EPS past 3/5Y	- -	ROIC	-22.36%	52W Low	10.92 35.35%	Perf 3Y	-
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	- -	Gross Margin	76.67%	Volatility	5.37% 6.45%	Perf 5Y	-
Dividend TTM	-	EV/Sales	4.37	EPS Y/Y TTM	-148.57%	Oper. Margin	-51.25%	ATR (14)	0.86	Perf 10Y	-
Dividend Ex-Date	-	Quick Ratio	9.80	Sales Y/Y TTM	39.97%	Profit Margin	-87.39%	RSI (14)	55.19	Recom	1.00
Dividend Gr. 3/5Y	- -	Current Ratio	11.09	EPS Q/Q	-108.35%	SMA20	1.82%	Beta	-	Target Price	20.60
Payout	-	Debt/Eq	0.10	Sales Q/Q	57.71%	SMA50	12.60%	Rel Volume	0.22	Prev Close	15.20
Employees	56	LT Debt/Eq	0.10	Earnings	Nov 11 AMC	SMA200	9.16%	Avg Volume	96.01K	Price	14.78
IPO	Jul 31, 2025	Option/Short	No / Yes	EPS/Sales Surpr.	-104.21% 19.10%	Trades		Volume	21,321	Change	-2.76%

Date	Action	Analyst	Rating Change	Price Target Change
Aug-25-25	Initiated	Piper Sandler	Overweight	$18
Aug-25-25	Initiated	Jefferies	Buy	$19
Aug-25-25	Initiated	Goldman	Buy	$20
Aug-25-25	Initiated	BTIG Research	Buy	$23

Dec-03-25 07:00AM	Shoulder Innovations Announces Strategic Partnership with INS to Introduce a Robotic Platform for Shoulder Arthroplasty (PR Newswire)
Nov-19-25 04:05PM	Shoulder Innovations to Participate in the Piper Sandler 37th Annual Healthcare Conference (PR Newswire)
Nov-12-25 02:35PM	Why Shoulder Innovations Stock Is Skyrocketing Today (Motley Fool) +32.04%
Nov-11-25 04:05PM	Shoulder Innovations Reports Third Quarter 2025 Financial Results and Increases Full-Year Revenue Guidance (PR Newswire)
Nov-06-25 05:07PM	A-Mark reports Q1 loss; announces acquisition, name and listing change (Investing.com)
04:05PM	Loading…
Nov-04-25 04:05PM	Shoulder Innovations to Participate in the Jefferies Global Healthcare Conference (PR Newswire)
Oct-21-25 08:07AM	Gold and silver miners tumble as precious metals retreat from record highs (Investing.com)
Oct-20-25 04:05PM	Shoulder Innovations to Report Third Quarter 2025 Financial Results on November 11, 2025 (PR Newswire)
Oct-14-25 02:09PM	3 Healthcare Companies Insiders Are Buying (MarketBeat)
Sep-25-25 10:30AM	Aya Gold & Silver falls after short seller alleges resource inflation (Investing.com)
Sep-22-25 06:18AM	Shoulder Innovations Announces Full Commercial Launch of the InSet 70 Humeral Stem (PR Newswire)
Sep-09-25 07:00AM	Shoulder Innovations Reports Second Quarter 2025 Financial Results (PR Newswire) -5.79%
Sep-01-25 06:34AM	2 New IPOs on the Street Morgan Stanley Chooses the Superior Stock to Buy (TipRanks)
Aug-28-25 04:05PM	Shoulder Innovations to Report Second Quarter 2025 Financial Results on September 9, 2025 (PR Newswire) -6.09%
Aug-25-25 09:36AM	Figma initiated, Okta upgraded: Wall Street's top analyst calls (The Fly) +18.17%
08:55AM	Loading…
Jul-31-25 08:55AM	NYSE Content Advisory: Pre-market update + Figma valued at over $19 billion in IPO (PR Newswire)

Shoulder Innovations, Inc. manufactures medical devices. It has developed a shoulder replacement system. The company was founded by Stephen B. Gunther and Michael DeVries in 2009 and is headquartered in Grand Rapids, MI.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Points Jeffrey S.	CHIEF FINANCIAL OFFICER	Sep 11 '25	Option Exercise	2.48	13,264	32,900	50,845	Sep 15 04:25 PM
Points Jeffrey S.	CHIEF FINANCIAL OFFICER	Sep 12 '25	Buy	15.67	1,600	25,072	52,445	Sep 15 04:25 PM
Blue David Lawrence	SEE REMARKS	Sep 12 '25	Option Exercise	2.16	94,394	204,135	138,331	Sep 15 04:21 PM
Ball Robert Joseph	CEO & EXECUTIVE CHAIRMAN	Sep 12 '25	Buy	15.49	6,000	92,945	111,259	Sep 15 04:15 PM
Ball Robert Joseph	CEO & EXECUTIVE CHAIRMAN	Sep 11 '25	Buy	14.90	2,000	29,810	105,259	Sep 15 04:15 PM
Ahearn Matthew Fraser	CHIEF OPERATING OFFICER	Sep 11 '25	Option Exercise	2.02	107,345	217,271	215,379	Sep 15 04:09 PM
Gilde Healthcare Holding B.V.	10% Owner	Aug 01 '25	Buy	15.00	100,000	1,500,000	2,380,482	Aug 05 06:37 PM
Carusi Michael A	Director	Aug 01 '25	Buy	15.00	266,666	3,999,990	1,885,136	Aug 05 04:05 PM
Buchholz Richard	Director	Aug 01 '25	Buy	15.00	5,000	75,000	12,666	Aug 05 04:05 PM
LSV Associates II, LLC	Former 10% Owner	Aug 01 '25	Buy	15.00	266,666	3,999,990	1,885,136	Aug 05 04:05 PM
Pardo Geoffrey B	Director	Aug 01 '25	Buy	15.00	100,000	1,500,000	2,380,482	Aug 05 04:05 PM
Tansey Casey M	Director	Aug 01 '25	Buy	15.00	40,000	600,000	47,666	Aug 05 04:05 PM
Points Jeffrey S.	CHIEF FINANCIAL OFFICER	Aug 01 '25	Buy	15.00	50	750	50	Aug 05 04:05 PM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

SI

Shoulder Innovations Inc

Upgrade your FINVIZ experience